Madrigal Pharmaceuticals shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Madrigal Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Madrigal Pharmaceuticals held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Madrigal Pharmaceuticals by Rhenman & Partners Asset Management AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.2M | 15k | 212.22 |
| 2024-06-30 | $7.4M | 27k | 280.16 |
| 2024-03-31 | $9.7M | 37k | 267.04 |
| 2019-09-30 | $2.6M | 30k | 86.23 |
| 2019-06-30 | $3.9M | 37k | 104.82 |
| 2019-03-31 | $3.4M | 27k | 125.25 |
More positions owned by Rhenman & Partners Asset Management AB
View all positions for Rhenman & Partners Asset Management AB